Differential effects of endurance training and creatine depletion on regional mitochondrial adaptations in rat skeletal muscle.
To examine the combined effects of 2-week endurance training and 3-week feeding with beta-guanidinopropionic acid (GPA) on regional adaptability of skeletal muscle mitochondria, intermyofibrillar mitochondria (IFM) and subsarcolemmal mitochondria (SSM) were isolated from quadriceps muscles of sedentary control, trained control, sedentary GPA-fed and trained GPA-fed rats. Mitochondrial oxidative phosphorylation was assessed polarographically by using pyruvate plus malate, succinate (plus rotenone), and ascorbate plus N,N,N',N'-tetramethyl-p-phenylenediamine (TMPD) (plus antimycin) as respiratory substrates. Assays of cytochrome c oxidase and F(1)-ATPase activities were also performed. In sedentary control rats, IFM exhibited a higher oxidative capacity than SSM, whereas F(1)-ATPase activities were similar. Training increased the oxidative phosphorylation capacity of mitochondria with both pyruvate plus malate and ascorbate plus TMPD as substrates, with no differences between IFM and SSM. In contrast, the GPA diet mainly improved the overall SSM oxidative phosphorylation capacity, irrespective of the substrate used. Finally, the superimposition of training to feeding with GPA strongly increased both oxidase and enzymic activities in SSM, whereas no cumulative effects were found in IFM mitochondria. It therefore seems that endurance training and feeding with GPA, which are both known to alter the energetic status of the muscle cell, might mediate distinct biochemical adaptations in regional skeletal muscle mitochondria.
Roussel
D
D
Laboratoire de Physiologie des Régulations Energétiques, Cellulaires et Moléculaires, UMR 5578 CNRS, 8 Avenue Rockefeller, 69373 Lyon Cedex 08, France.
Lhenry
F
F
Ecochard
L
L
Sempore
B
B
Rouanet
J L
JL
Favier
R
R
D000818:Animals; D000968:Antimycin A / Q000031:analogs & derivatives* / Q000494:pharmacology; D001205:Ascorbic Acid / Q000378:metabolism; D003401:Creatine / Q000502:physiology*; D004032:Diet; D003576:Electron Transport Complex IV / Q000378:metabolism; D006146:Guanidines / Q000494:pharmacology; D006801:Humans; D008293:Malates / Q000378:metabolism; D008297:Male; D008928:Mitochondria / Q000201:enzymology / Q000378:metabolism*; D018482:Muscle, Skeletal / Q000378:metabolism*; D010085:Oxidative Phosphorylation; D010101:Oxygen Consumption; D010805:Physical Conditioning, Animal; D011422:Propionates / Q000494:pharmacology; D006180:Proton-Translocating ATPases / Q000378:metabolism; D019289:Pyruvic Acid / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D012402:Rotenone / Q000494:pharmacology; D012508:Sarcolemma / Q000378:metabolism; D019802:Succinic Acid / Q000378:metabolism; D013772:Tetramethylphenylenediamine / Q000494:pharmacology; D013997:Time Factors
D006146:Guanidines; D008293:Malates; D011422:Propionates; D012402:Rotenone; C032456:antimycin; D000968:Antimycin A; C030298:malic acid; D019289:Pyruvic Acid; D019802:Succinic Acid; D003576:Electron Transport Complex IV; D006180:Proton-Translocating ATPases; D003401:Creatine; D013772:Tetramethylphenylenediamine; D001205:Ascorbic Acid; C005775:guanidinopropionic acid